OOIR: Observatory of International Research

Papers

(The TQCC of Breast Cancer is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”	140
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can	65
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud	54
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients	45
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients	39
Patterns of ipsilateral breast tumor recurrence following partial vs. whole-breast irradiation: a retrospective comparative study of breast-conserving therapy	32
Low-carbohydrate diet score and risk of breast cancer: findings from a prospective cohort study	31
Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study	27
Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer society	27
Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances	25
Factors associated with post acute care utilization after mastectomy for breast cancer patients	23
Development of a deep learning-based automated diagnostic system (DLADS) for classifying mammographic lesions — a first large-scale multi-institutional clinical trial in Japan	21
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan	20
The role of C1orf50 in breast cancer progression and prognosis	20
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence	20
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis	19
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	19
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan	18
Real-world analysis of interstitial lung disease/pneumonitis in Japanese patients with breast cancer receiving trastuzumab deruxtecan	18
Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study	18
Emerging roles of KIR2DL4 in cancer immunotherapy	17
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment	17
Exploring a specialized lactylation pattern to predict the prognosis and sensitivity of immunotherapy in breast cancer via machine learning	17
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial	17
Impact of margin status on ipsilateral breast tumor recurrence after breast-conserving treatment for patients with breast cancer who received neoadjuvant chemotherapy: a retrospective multi-institutio	16

Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients	16
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from	16
Prospective randomized-controlled trial: efficacy of 37 °C-preheated thermoplastic elastomer (TPE) bolus in postoperative radiotherapy for breast cancer patients	16
Safety of radiotherapy in patients undergoing breast reconstruction based on patient-reported outcomes: a multicenter collaborative study	16
Relevance of the MHC region for breast cancer susceptibility in Asians	16
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual p	15
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)	14
SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer	14
Glutaminase (GLS1) gene expression in primary breast cancer	14
ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer	14
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan	14
Efficacy of xeno-free induced mesenchymal stem/stromal cells in enhancing autologous fat graft survival	13
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor	13
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study	13
Low-progesterone receptor expression predicts nodal pathological complete response after neoadjuvant chemotherapy in premenopausal patients with ER-positive/HER2-negative breast cancer	13
Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan	13
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis	12
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a	12
Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy	12
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer	12
Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2− advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis	12
CT findings of lung injury during breast cancer treatment	12
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia	12
An investigation to identify the factors for negative sentinel lymph node metastasis in early breast cancer cases	11
Prognostic impact of tumor‑associated stroma in triple-negative breast cancer	11
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol	11
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status	11
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment	11
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches	11
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study	11
Chemotherapy and cognition: a promising start, but mechanistic clarity still needed	11
Impact of artificial intelligence in breast cancer screening with mammography	11
Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1	11
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels	11
21-gene recurrence score predictive of the benefit of postoperative radiotherapy after breast-conserving surgery for elderly patients with T1N0 and luminal breast cancer	11
Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions	10
Breast cancer screening guidelines: discrepancies raise concerns about validity	10
Breast reconstruction-related complications from postmastectomy radiation therapy in stage II–III breast cancer: sub-analysis of a multi-institutional observational study (Reborn-03)	10
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes	10
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models	10
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options	10
Association between preoperative grip strength and postoperative upper extremity impairments in patients with breast cancer: a retrospective cohort study	10
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein	10
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry—clinical implications including chemosensitivity of breast cancer with low estrogen r	10
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018	10
Association between chronic pain and quality of life in long-term breast cancer survivors: a prospective analysis	10
Capecitabine with aromatase inhibitors in the front-line therapy for metastatic breast cancer	10
The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees	10
Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)	10
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up	10

Early outcomes of accelerated partial breast irradiation and dosimetric comparison of volumetric modulated arc therapy and three-dimensional conformal radiotherapy	9
The impact of specialist palliative care on healthcare utilization among patients with breast cancer: a nationwide register-based cohort study	9
Color differences of skin paddles using the free flap for autologous breast reconstruction in Asian patients	9
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes	9
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort	9
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast	9
Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells	9
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population	9
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity	8
Patient satisfaction on prescription refill systems for breast cancer patients in Japan using a digital self-administered survey	8
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy	8
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?	8
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers	8
Performance analysis of screening mammography in Asian women under 40 years	8
Marital status as an independent prognostic factor in male breast cancer: a SEER-based cohort study	8
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis	8
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes	8
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results	8
Response to letter to the editor: Risk of endometrial cancer among breast cancer survivors in Japan—a matched cohort study	8
Evaluating high-risk breast cancer surveillance outcomes in BRCA mutation carriers	8
Correction: The therapeutic potential of high-intensity interval training in a breast cancer model: focus on the Hippo signaling pathway	8
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan	8
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer	8
Impact of radiation therapy on breast satisfaction and health-related quality of life after breast reconstruction: a multicenter cross-sectional controlled study (Reborn study-02)	8
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort	8
Efficacy and prognostic predictors of primary systemic therapy for de novo Stage IV breast cancer. Exploratory analysis of JCOG1017 PRIM-BC	8
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer	8
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors	7
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition	7
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT	7
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data	7
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer	7
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study	7
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER databas	7
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer	7
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy	7
Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties	7
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants	7
Management of nausea and vomiting induced by antibody–drug conjugates	7
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer	7
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study	7
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual	6
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy	6
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands	6
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgery	6
Impact of community-based exercise on fatigue in early breast cancer survivors: identifying potential determinants of change	6
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer	6
Prognostic significance of peripheral myeloid-derived suppressor cells in advanced breast cancer	6
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	6
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study	6
Timing of postmastectomy radiation therapy in two-stage expander/implant-based breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese breast cancer society clinical practic	6
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management	6
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data	6
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study	6
Characterization of gut microbiota dysbiosis in breast cancer patients	6
Specific types of anxiety regarding radiation therapy in patients with breast cancer: a longitudinal study	6
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan	6
Alcohol consumption and breast lesions: targets for risk-based screening in high-risk Italian women	6
Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis	6
Comparative study of the usefulness of adjunctive tomosynthesis in breast cancer screening by mammography and ultrasound in Japan	6
Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis	6
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study	6
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis	6